Abstract
Aeroallergens are the most common triggers for the development of asthma. Recent birth cohort studies have identified viral infections occurring against a background of aeroallergen sensitization as a potent risk factor for initiation of asthma. Viral infection enhances immunopathogenic potential of pre-existing inhalant allergy via modulating airway mucosal dendritic cells. By using an allergen inhalation challenge clinical model, studies have shown that the late asthma response (LAR) is associated with more pronounced allergen-induced airway inflammation and airway hyperresponsiveness. The degree of airway eosinophilia, regulated by bone marrow progenitor cells and interleukin-5 level, correlates with the magnitude of the LAR and the increase in hyperresponsiveness. Both myeloid and plasmacytoid dendritic cell subsets have been involved in the pathogenesis of allergen-induced LAR. Myeloid dendritic cells are responsible for the allergen presentation and induction of inflammation and plasmacytoid dendritic cells play a role in the resolution of allergen-induced inflammation. A variety of potential new classes of asthma medication has also been evaluated with the allergen inhalation challenge in mild asthmatic subjects. Examples are TPI ASM8, an inhaled anti-sense oligonucleotide drug product, which attenuated both early and LARs via inhibition of the target gene mRNA of chemokine receptor 3, and the common β chain of interleukin-3, interleukin-5 and granulocyte–macrophage colony-stimulating factor receptor. Anti-human antibody interleukin-13 (IM-638) significantly attenuated both early and late allergen-induced asthma response. Pitrakinra, which targets both interleukin-4 and interleukin-13, substantially diminishes allergen-induced airway responses. Allergen-induced airway responses are a valuable way to evaluate the activity of possible new therapies in asthmatic airways.
Similar content being viewed by others
References
Allakhverdi Z, Allam M, Renzi PM (2002) Inhibition of antigen-induced eosinophilia and airway hyperresponsiveness by antisense oligonucleotides directed against the common beta chain of IL-3, IL-5, GM-CSF receptors in a rat model of allergic asthma. Am J Respir Crit Care Med 165(7):1015–1021
Allakhverdi Z, Allam M, Guimond A et al (2006) Multitargeted approach using antisense oligonucleotides for the treatment of asthma. Ann NY Acad Sci 1082:62–73
Allam M, Renzi PM (2001) Inhibition of GM-CSF/IL-3/IL-5 signaling by antisense oligodeoxynucleotides targeting the common beta chain of their receptors. Antisense Nucleic Acid Drug Dev 11(5):289–300
Bateman ED, Hurd SS, Barnes PJ et al (2008) Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 31(1):143–178
Beyer M, Bartz H, Horner K et al (2004) Sustained increases in numbers of pulmonary dendritic cells after respiratory syncytial virus infection. J Allergy Clin Immunol 113(1):127–133
Black JL, Panettieri RA Jr, Banerjee A et al (2012) Airway smooth muscle in asthma: just a target for bronchodilation? Clin Chest Med 33(3):543–558
Blanchard C, Mishra A, Saito-Akei H et al (2005) Inhibition of human interleukin-13-induced respiratory and oesophageal inflammation by anti-human-interleukin-13 antibody (CAT-354). Clin Exp Allergy 35(8):1096–1103
Boulet LP, Chapman KR, Cote J et al (1997) Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response. Am J Respir Crit Care Med 155(6):1835–1840
Boulet LP, Turcotte H, Laviolette M et al (2000) Airway hyperresponsiveness, inflammation, and subepithelial collagen deposition in recently diagnosed versus long-standing mild asthma. Influence of inhaled corticosteroids. Am J Respir Crit Care Med 162((4 Pt 1)):1308–1313
Boulet LP, Gauvreau G, Boulay ME et al (2007) The allergen bronchoprovocation model: an important tool for the investigation of new asthma anti-inflammatory therapies. Allergy 62(10):1101–1110
Bousquet J, Chanez P, Lacoste JY et al (1990) Eosinophilic inflammation in asthma. N Engl J Med 323(15):1033–1039
Boyce JA (2005) Eicosanoid mediators of mast cells: receptors, regulation of synthesis, and pathobiologic implications. Chem Immunol Allergy 87:59–79
Bradding P, Holgate ST (1996) The mast cell as a source of cytokines in asthma. Ann NY Acad Sci 796:272–281
Braun-Fahrlander C, Riedler J, Herz U et al (2002) Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med 347(12):869–877
Bree A, Schlerman FJ, Wadanoli M et al (2007) IL-13 blockade reduces lung inflammation after Ascaris suum challenge in cynomolgus monkeys. J Allergy Clin Immunol 119(5):1251–1257
Brewster CE, Howarth PH, Djukanovic R et al (1990) Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 3(5):507–511
Brown RH, Pearse DB, Pyrgos G et al (2006) The structural basis of airways hyperresponsiveness in asthma. J Appl Physiol 101(1):30–39
Cartier A, Thomson NC, Frith PA et al (1982) Allergen-induced increase in bronchial responsiveness to histamine: relationship to the late asthmatic response and change in airway caliber. J Allergy Clin Immunol 70(3):170–177
Choy DF, Modrek B, Abbas AR et al (2011) Gene expression patterns of Th2 inflammation and intercellular communication in asthmatic airways. J Immunol 186(3):1861–1869
Copenhaver CC, Gern JE, Li Z et al (2004) Cytokine response patterns, exposure to viruses, and respiratory infections in the first year of life. Am J Respir Crit Care Med 170(2):175–180
Corren J, Lemanske RF, Hanania NA et al (2011) Lebrikizumab treatment in adults with asthma. N Engl J Med 365(12):1088–1098
Davis BE, Todd DC, Cockcroft DW (2005) Effect of combined montelukast and desloratadine on the early asthmatic response to inhaled allergen. J Allergy Clin Immunol 116(4):768–772
Davis BE, Illamperuma C, Gauvreau GM et al (2009) Single-dose desloratadine and montelukast and allergen-induced late airway responses. Eur Respir J 33(6):1302–1308
de Heer HJ, Hammad H, Soullie T et al (2004) Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J Exp Med 200(1):89–98
Dorman SC, Sehmi R, Gauvreau GM et al (2004) Kinetics of bone marrow eosinophilopoiesis and associated cytokines after allergen inhalation. Am J Respir Crit Care Med 169(5):565–572
Dorsch W, Baur X, Emslander HP et al (1980) Pathogenesis and treatment of allergen-induced late bronchial obstruction (author’s transl). Prax Klin Pneumol 34(8):461–468
Dua B, Watson RM, Gauvreau GM et al (2010) Myeloid and plasmacytoid dendritic cells in induced sputum after allergen inhalation in subjects with asthma. J Allergy Clin Immunol 126(1):133–139
Elbashir SM, Harborth J, Lendeckel W et al (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411(6836):494–498
Fahy JV, Fleming HE, Wong HH et al (1997) The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects. Am J Respir Crit Care Med 155(6):1828–1834
Farrell E, O’Connor TM, Duong M et al (2007) Circulating myeloid and plasmacytoid dendritic cells after allergen inhalation in asthmatic subjects. Allergy 62(10):1139–1145
Ferrari N, Seguin R, Renzi P (2011) Oligonucleotides: a multi-targeted approach for the treatment of respiratory diseases. Future Med Chem 3(13):1647–1662
Fish SC, Donaldson DD, Goldman SJ et al (2005) IgE generation and mast cell effector function in mice deficient in IL-4 and IL-13. J Immunol 174(12):7716–7724
Fortin M, Ferrari N, Higgins ME et al (2006) Effects of antisense oligodeoxynucleotides targeting CCR3 on the airway response to antigen in rats. Oligonucleotides 16(3):203–212
Foster PS, Webb DC, Yang M et al (2003) Dissociation of T helper type 2 cytokine-dependent airway lesions from signal transducer and activator of transcription 6 signalling in experimental chronic asthma. Clin Exp Allergy 33(5):688–695
Gauvreau GM, Doctor J, Watson RM et al (1996) Effects of inhaled budesonide on allergen-induced airway responses and airway inflammation. Am J Respir Crit Care Med 154(5):1267–1271
Gauvreau GM, Jordana M, Watson RM et al (1997) Effect of regular inhaled albuterol on allergen-induced late responses and sputum eosinophils in asthmatic subjects. Am J Respir Crit Care Med 156(6):1738–1745
Gauvreau GM, Watson RM, O’Byrne PM (1999) Kinetics of allergen-induced airway eosinophilic cytokine production and airway inflammation. Am J Respir Crit Care Med 160(2):640–647
Gauvreau GM, Lee JM, Watson RM et al (2000) Increased numbers of both airway basophils and mast cells in sputum after allergen inhalation challenge of atopic asthmatics. Am J Respir Crit Care Med 161(5):1473–1478
Gauvreau GM, Boulet LP, Cockcroft DW et al (2008) Antisense therapy against CCR3 and the common beta chain attenuates allergen-induced eosinophilic responses. Am J Respir Crit Care Med 177(9):952–958
Gauvreau GM, Boulet LP, Cockcroft DW et al (2011a) Effects of interleukin-13 blockade on allergen-induced airway responses in mild atopic asthma. Am J Respir Crit Care Med 183(8):1007–1014
Gauvreau GM, Pageau R, Seguin R et al (2011b) Dose-response effects of TPI ASM8 in asthmatics after allergen. Allergy 66(9):1242–1248
Gill MA, Palucka AK, Barton T et al (2005) Mobilization of plasmacytoid and myeloid dendritic cells to mucosal sites in children with respiratory syncytial virus and other viral respiratory infections. J Infect Dis 191(7):1105–1115
Greaves DR, Wang W, Dairaghi DJ et al (1997) CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3alpha and is highly expressed in human dendritic cells. J Exp Med 186(6):837–844
Grunig G, Warnock M, Wakil AE et al (1998) Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282(5397):2261–2263
Hammad H, Lambrecht BN (2006) Recent progress in the biology of airway dendritic cells and implications for understanding the regulation of asthmatic inflammation. J Allergy Clin Immunol 118(2):331–336
Hammad H, de Vries VC, Maldonado-Lopez R et al (2004) Differential capacity of CD8+ alpha or CD8− alpha dendritic cell subsets to prime for eosinophilic airway inflammation in the T-helper type 2-prone milieu of the lung. Clin Exp Allergy 34(12):1834–1840
He R, Geha RS (2010) Thymic stromal lymphopoietin. Ann NY Acad Sci 1183:13–24
Hebenstreit D, Wirnsberger G, Horejs-Hoeck J et al (2006) Signaling mechanisms, interaction partners, and target genes of STAT6. Cytokine Growth Factor Rev 17(3):173–188
Holgate ST (2007) The epithelium takes centre stage in asthma and atopic dermatitis. Trends Immunol 28(6):248–251
Holt PG, Sly PD (2012) Viral infections and atopy in asthma pathogenesis: new rationales for asthma prevention and treatment. Nat Med 18(5):726–735
Holt PG, Strickland DH (2010) Interactions between innate and adaptive immunity in asthma pathogenesis: new perspectives from studies on acute exacerbations. J Allergy Clin Immunol 125(5):963–972
Holt PG, Thomas WR (2005) Sensitization to airborne environmental allergens: unresolved issues. Nat Immunol 6(10):957–960
Holt PG, Strickland DH, Wikstrom ME et al (2008) Regulation of immunological homeostasis in the respiratory tract. Nat Rev Immunol 8(2):142–152
Holt PG, Rowe J, Kusel M et al (2010) Toward improved prediction of risk for atopy and asthma among preschoolers: a prospective cohort study. J Allergy Clin Immunol 125(3):653–659
Illi S, von Mutius E, Lau S et al (2001) Early childhood infectious diseases and the development of asthma up to school age: a birth cohort study. BMJ 322(7283):390–395
Illi S, von Mutius E, Lau S et al (2006) Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study. Lancet 368(9537):763–770
Jackson DJ, Evans MD, Gangnon RE et al (2012) Evidence for a causal relationship between allergic sensitization and rhinovirus wheezing in early life. Am J Respir Crit Care Med 185(3):281–285
Jacoby DB, Costello RM, Fryer AD (2001) Eosinophil recruitment to the airway nerves. J Allergy Clin Immunol 107(2):211–218
Janson C, Anto J, Burney P et al (2001) The European Community Respiratory Health Survey: what are the main results so far? European Community Respiratory Health Survey II. Eur Respir J 18(3):598–611
Jayasena SD (1999) Aptamers: an emerging class of molecules that rival antibodies in diagnostics. Clin Chem 45(9):1628–1650
Jeffery P, Zhu J (2002) Mucin-producing elements and inflammatory cells. Novartis Found Symp 248:51–68
Kasaian MT, Donaldson DD, Tchistiakova L et al (2007) Efficacy of IL-13 neutralization in a sheep model of experimental asthma. Am J Respir Cell Mol Biol 36(3):368–376
Kasaian MT, Tan XY, Jin M et al (2008) Interleukin-13 neutralization by two distinct receptor blocking mechanisms reduces immunoglobulin E responses and lung inflammation in cynomolgus monkeys. J Pharmacol Exp Ther 325(3):882–892
Kay AB (2001) Allergy and allergic diseases. Second of two parts. N Engl J Med 344(2):109–113
Kelly MM, O’Connor TM, Leigh R et al (2010) Effects of budesonide and formoterol on allergen-induced airway responses, inflammation, and airway remodeling in asthma. J Allergy Clin Immunol 125(2):349–356
Kirby JG, Robertson DG, Hargreave FE et al (1986) Asthmatic responses to inhalation of anti-human IgE. Clin Allergy 16(3):191–194
Kirkham S, Sheehan JK, Knight D et al (2002) Heterogeneity of airways mucus: variations in the amounts and glycoforms of the major oligomeric mucins MUC5AC and MUC5B. Biochem J 361(Pt 3):537–546
Krieg AM, Yi AK, Matson S et al (1995) CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374(6522):546–549
Krieg AM, Matson S, Fisher E (1996) Oligodeoxynucleotide modifications determine the magnitude of B cell stimulation by CpG motifs. Antisense Nucleic Acid Drug Dev 6(2):133–139
Kulig M, Bergmann R, Tacke U et al (1998) Long-lasting sensitization to food during the first two years precedes allergic airway disease. The MAS Study Group, Germany. Pediatr Allergy Immunol 9(2):61–67
Kusel MM, de Klerk NH, Kebadze T et al (2007) Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J Allergy Clin Immunol 119(5):1105–1110
Lai H, Rogers DF (2010) New pharmacotherapy for airway mucus hypersecretion in asthma and COPD: targeting intracellular signaling pathways. J Aerosol Med Pulm Drug Deliv 23(4):219–231
Lambrecht BN, Hammad H (2009) Biology of lung dendritic cells at the origin of asthma. Immunity 31(3):412–424
Lambrecht BN, De Veerman M, Coyle AJ et al (2000a) Myeloid dendritic cells induce Th2 responses to inhaled antigen, leading to eosinophilic airway inflammation. J Clin Invest 106(4):551–559
Lambrecht BN, Peleman RA, Bullock GR et al (2000b) Sensitization to inhaled antigen by intratracheal instillation of dendritic cells. Clin Exp Allergy 30(2):214–224
Lamkhioued B, Renzi PM, Abi-Younes S et al (1997) Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. J Immunol 159(9):4593–4601
Lamkhioued B, Abdelilah SG, Hamid Q et al (2003) The CCR3 receptor is involved in eosinophil differentiation and is up-regulated by Th2 cytokines in CD34+ progenitor cells. J Immunol 170(1):537–547
LaPorte SL, Juo ZS, Vaclavikova J et al (2008) Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system. Cell 132(2):259–272
Leigh R, Vethanayagam D, Yoshida M et al (2002) Effects of montelukast and budesonide on airway responses and airway inflammation in asthma. Am J Respir Crit Care Med 166(9):1212–1217
Li X, Wilson JW (1997) Increased vascularity of the bronchial mucosa in mild asthma. Am J Respir Crit Care Med 156(1):229–233
Limb SL, Brown KC, Wood RA et al (2005) Irreversible lung function deficits in young adults with a history of childhood asthma. J Allergy Clin Immunol 116(6):1213–1219
Lively TN, Kossen K, Balhorn A et al (2008) Effect of chemically modified IL-13 short interfering RNA on development of airway hyperresponsiveness in mice. J Allergy Clin Immunol 121(1):88–94
Lowe AJ, Hosking CS, Bennett CM et al (2007) Skin prick test can identify eczematous infants at risk of asthma and allergic rhinitis. Clin Exp Allergy 37(11):1624–1631
Ma Y, Hayglass KT, Becker AB et al (2007a) Novel recombinant interleukin-13 peptide-based vaccine reduces airway allergic inflammatory responses in mice. Am J Respir Crit Care Med 176(5):439–445
Ma Y, Hayglass KT, Becker AB et al (2007b) Novel cytokine peptide-based vaccines: an interleukin-4 vaccine suppresses airway allergic responses in mice. Allergy 62(6):675–682
Mann MJ, Dzau VJ (2000) Therapeutic applications of transcription factor decoy oligonucleotides. J Clin Invest 106(9):1071–1075
Martinez FD, Wright AL, Taussig LM et al (1995) Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 332(3):133–138
McKenzie GJ, Fallon PG, Emson CL et al (1999) Simultaneous disruption of interleukin (IL)-4 and IL-13 defines individual roles in T helper cell type 2-mediated responses. J Exp Med 189(10):1565–1572
McWilliam AS, Napoli S, Marsh AM et al (1996) Dendritic cells are recruited into the airway epithelium during the inflammatory response to a broad spectrum of stimuli. J Exp Med 184(6):2429–2432
McWilliam AS, Marsh AM, Holt PG (1997) Inflammatory infiltration of the upper airway epithelium during Sendai virus infection: involvement of epithelial dendritic cells. J Virol 71(1):226–236
Molina C, Brun J, Coulet M et al (1977) Immunopathology of the bronchial mucosa in ‘late onset’ asthma. Clin Allergy 7(2):137–145
Nakajima H, Takatsu K (2007) Role of cytokines in allergic airway inflammation. Int Arch Allergy Immunol 142(4):265–273
O’Byrne PM, Dolovich J, Hargreave FE (1987) Late asthmatic responses. Am Rev Respir Dis 136(3):740–751
Oddy WH, de Klerk NH, Sly PD et al (2002) The effects of respiratory infections, atopy, and breastfeeding on childhood asthma. Eur Respir J 19(5):899–905
Ordonez CL, Khashayar R, Wong HH et al (2001) Mild and moderate asthma is associated with airway goblet cell hyperplasia and abnormalities in mucin gene expression. Am J Respir Crit Care Med 163(2):517–523
Ozier A, Allard B, Bara I et al (2011) The pivotal role of airway smooth muscle in asthma pathophysiology. J Allergy (Cairo) 2011:742710
Palmer-Crocker RL, Hughes CC, Pober JS (1996) IL-4 and IL-13 activate the JAK2 tyrosine kinase and Stat6 in cultured human vascular endothelial cells through a common pathway that does not involve the gamma c chain. J Clin Invest 98(3):604–609
Peat JK, Salome CM, Woolcock AJ (1990) Longitudinal changes in atopy during a 4-year period: relation to bronchial hyperresponsiveness and respiratory symptoms in a population sample of Australian school children. J Allergy Clin Immunol 85(1 Pt 1):65–74
Pepe C, Foley S, Shannon J et al (2005) Differences in airway remodeling between subjects with severe and moderate asthma. J Allergy Clin Immunol 116(3):544–549
Pepys J, Hargreave FE, Chan M et al (1968) Inhibitory effects of disodium cromoglycate on allergen-inhalation tests. Lancet 2(7560):134–137
Perkins C, Wills-Karp M, Finkelman FD (2006) IL-4 induces IL-13-independent allergic airway inflammation. J Allergy Clin Immunol 118(2):410–419
Pini L, Hamid Q, Shannon J et al (2007) Differences in proteoglycan deposition in the airways of moderate and severe asthmatics. Eur Respir J 29(1):71–77
Power CA, Church DJ, Meyer A et al (1997) Cloning and characterization of a specific receptor for the novel CC chemokine MIP-3α from lung dendritic cells. J Exp Med 186(6):825–835
Rhodes HL, Thomas P, Sporik R et al (2002) A birth cohort study of subjects at risk of atopy: twenty-two-year follow-up of wheeze and atopic status. Am J Respir Crit Care Med 165(2):176–180
Robinson DS (2010) The role of the T cell in asthma. J Allergy Clin Immunol 126(6):1081–1091
Rousseau K, Byrne C, Griesinger G et al (2007) Allelic association and recombination hotspots in the mucin gene (MUC) complex on chromosome 11p15.5. Ann Hum Genet 71(Pt 5):561–569
Salvato G (2001) Quantitative and morphological analysis of the vascular bed in bronchial biopsy specimens from asthmatic and non-asthmatic subjects. Thorax 56(12):902–906
Sehmi R, Wood LJ, Watson R et al (1997) Allergen-induced increases in IL-5 receptor alpha-subunit expression on bone marrow-derived CD34+ cells from asthmatic subjects. A novel marker of progenitor cell commitment towards eosinophilic differentiation. J Clin Invest 100(10):2466–2475
Sherrill D, Stein R, Kurzius-Spencer M et al (1999) On early sensitization to allergens and development of respiratory symptoms. Clin Exp Allergy 29(7):905–911
Shimura S, Andoh Y, Haraguchi M et al (1996) Continuity of airway goblet cells and intraluminal mucus in the airways of patients with bronchial asthma. Eur Respir J 9(7):1395–1401
Sidhu SS, Yuan S, Innes AL et al (2010) Roles of epithelial cell-derived periostin in TGF-beta activation, collagen production, and collagen gel elasticity in asthma. Proc Natl Acad Sci USA 107(32):14170–14175
Sly PD, Boner AL, Bjorksten B et al (2008) Early identification of atopy in the prediction of persistent asthma in children. Lancet 372(9643):1100–1106
Smit JJ, Rudd BD, Lukacs NW (2006) Plasmacytoid dendritic cells inhibit pulmonary immunopathology and promote clearance of respiratory syncytial virus. J Exp Med 203(5):1153–1159
Stern DA, Morgan WJ, Wright AL et al (2007) Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study. Lancet 370(9589):758–764
Takayama G, Arima K, Kanaji T et al (2006) Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. J Allergy Clin Immunol 118(1):98–104
Thai P, Chen Y, Dolganov G et al (2005) Differential regulation of MUC5AC/Muc5ac and hCLCA-1/mGob-5 expression in airway epithelium. Am J Respir Cell Mol Biol 33(6):523–530
Turner SW, Heaton T, Rowe J et al (2007) Early-onset atopy is associated with enhanced lymphocyte cytokine responses in 11-year-old children. Clin Exp Allergy 37(3):371–380
Twentyman OP, Finnerty JP, Harris A et al (1990) Protection against allergen-induced asthma by salmeterol. Lancet 336(8727):1338–1342
Voynow JA, Rubin BK (2009) Mucins, mucus, and sputum. Chest 135(2):505–512
Vrugt B, Wilson S, Bron A et al (2000) Bronchial angiogenesis in severe glucocorticoid-dependent asthma. Eur Respir J 15(6):1014–1021
Webb DC, McKenzie AN, Koskinen AM et al (2000) Integrated signals between IL-13, IL-4, and IL-5 regulate airways hyperreactivity. J Immunol 165(1):108–113
Webb DC, Matthaei KI, Cai Y et al (2004) Polymorphisms in IL-4R alpha correlate with airways hyperreactivity, eosinophilia, and Ym protein expression in allergic IL-13−/− mice. J Immunol 172(2):1092–1098
Wenzel S, Wilbraham D, Fuller R et al (2007) Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies. Lancet 370(9596):1422–1431
Whittaker L, Niu N, Temann UA et al (2002) Interleukin-13 mediates a fundamental pathway for airway epithelial mucus induced by CD4 T cells and interleukin-9. Am J Respir Cell Mol Biol 27(5):593–602
Wills-Karp M (2004) Interleukin-13 in asthma pathogenesis. Immunol Rev 202:175–190
Wills-Karp M, Luyimbazi J, Xu X et al (1998) Interleukin-13: central mediator of allergic asthma. Science 282(5397):2258–2261
Wong CK, Cheung PF, Ip WK et al (2007) Intracellular signaling mechanisms regulating toll-like receptor-mediated activation of eosinophils. Am J Respir Cell Mol Biol 37(1):85–96
Woodruff PG, Boushey HA, Dolganov GM et al (2007) Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc Natl Acad Sci USA 104(40):15858–15863
Wynn TA (2003) IL-13 effector functions. Annu Rev Immunol 21:425–456
Yang G, Volk A, Petley T et al (2004) Anti-IL-13 monoclonal antibody inhibits airway hyperresponsiveness, inflammation and airway remodeling. Cytokine 28(6):224–232
Yoshida R, Nagira M, Kitaura M et al (1998) Secondary lymphoid-tissue chemokine is a functional ligand for the CC chemokine receptor CCR7. J Biol Chem 273(12):7118–7122
Zheng T, Liu W, Oh SY et al (2008) IL-13 receptor α2 selectively inhibits IL-13-induced responses in the murine lung. J Immunol 180(1):522–529
Ziegler SF, Artis D (2010) Sensing the outside world: TSLP regulates barrier immunity. Nat Immunol 11(4):289–293
Zurawski G, de Vries JE (1994) Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today 15(1):19–26
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ma, L.L., O’Byrne, P.M. The pharmacological modulation of allergen-induced asthma. Inflammopharmacol 21, 113–124 (2013). https://doi.org/10.1007/s10787-012-0155-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10787-012-0155-3